Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Radiologic Clinics of North America
|
February 8, 2005
Imaging hypoxia and angiogenesis in tumors
Joseph G Rajendran, Kenneth A Krohn
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2006
Expanding role of positron emission tomography in cancer of the uterine cervix
Joseph G Rajendran, Benjamin E Greer
Seminars in Nuclear Medicine
|
February 24, 2015
F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy
Joseph G Rajendran, Kenneth A Krohn
Medical Physics
|
September 8, 2018
Volume dependence in hypoxia-targeted dose escalation
Alexei V Chvetsov, Jing Zeng, Joseph G Rajendran
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2002
High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation
Joseph G Rajendran, Janet F Eary, William Bensinger, et al.
Cancer
|
July 13, 2002
Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography
Douglas S Hawkins, Joseph G Rajendran, Ernest U Conrad, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
August 19, 2009
A robust automated measure of average antibody staining in immunohistochemistry images
Kingshuk Roy Choudhury, Kevin J Yagle, Paul E Swanson, et al.
Medical Physics
|
February 26, 2017
Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation
Alexei V Chvetsov, Joseph G Rajendran, Jing Zeng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2004
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes
Joseph G Rajendran, Darrell R Fisher, Ajay K Gopal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2008
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose
Joseph G Rajendran, Ajay K Gopal, Darrel R Fisher, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Radiologic Clinics of North America
|
February 8, 2005
Imaging hypoxia and angiogenesis in tumors
Joseph G Rajendran, Kenneth A Krohn
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2006
Expanding role of positron emission tomography in cancer of the uterine cervix
Joseph G Rajendran, Benjamin E Greer
Seminars in Nuclear Medicine
|
February 24, 2015
F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy
Joseph G Rajendran, Kenneth A Krohn
Medical Physics
|
September 8, 2018
Volume dependence in hypoxia-targeted dose escalation
Alexei V Chvetsov, Jing Zeng, Joseph G Rajendran
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2002
High-dose 166Ho-DOTMP in myeloablative treatment of multiple myeloma: pharmacokinetics, biodistribution, and absorbed dose estimation
Joseph G Rajendran, Janet F Eary, William Bensinger, et al.
Cancer
|
July 13, 2002
Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography
Douglas S Hawkins, Joseph G Rajendran, Ernest U Conrad, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
August 19, 2009
A robust automated measure of average antibody staining in immunohistochemistry images
Kingshuk Roy Choudhury, Kevin J Yagle, Paul E Swanson, et al.
Medical Physics
|
February 26, 2017
Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation
Alexei V Chvetsov, Joseph G Rajendran, Jing Zeng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 8, 2004
High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes
Joseph G Rajendran, Darrell R Fisher, Ajay K Gopal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2008
Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose
Joseph G Rajendran, Ajay K Gopal, Darrel R Fisher, et al.
Page
of 4